These research findings may provide a theoretical basis for developing Hsp–Cu(II) as a new hypoglycemic nutritional supplement, and offer new ideas for the dietary food nutritional regulation to alleviate T2DM. This evidence concerns the gene HSP90B2P and type 2 diabetes mellitus.